ADAKVEO

crizanlizumab · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for ADAKVEO, covering 2019-11-15 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study [Phase 4]

See pricing